SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (260)8/28/1998 2:41:00 AM
From: aknahowRead Replies (2) | Respond to of 4974
 
Rick, this perhaps is not the proper forum but while I understand the lament about biotech stocks I am unable to understand why you do not believe the F.D.A. insistence on determination of drug efficiency as well as safety is not one of the major causes of the decline in this industry sector. What do you see as the solution to reducing the cost of clinical trials?

How will biotechs raise capital in a bear or even non bull market?



To: scaram(o)uche who wrote (260)8/28/1998 3:02:00 PM
From: scaram(o)ucheRespond to of 4974
 
Just a quick note....

I'd like this to be clear........I don't regard the phase II for Parkinson's (1508Y) or the phase I (palliative, 1553A) for Alzheimer's as anything other than crap shoots.

If I had to order projects according to my enthusiasm, it would be...... VGCC-pain, BMY, Novartis-epilepsy, 1508Y, caspase, 1553A, Novartis-stroke/other, and VGCC-stroke (Lilly, if alive).

But, since I consider VGCC-pain *alone* to be worth more than the current market cap....... since I consider the Novartis project *alone* to be worth more than the current market cap...... since I consider the patents and screening technology *alone* to be worth more than the current market cap, and...... since I consider the BMY (Alzheimer's, Abeta inhibitors) project *alone* to be worth more than the current market cap, does it matter that the AChR projects are crap shoots??

That's all I'm going to say about SIBI, or, if I do have further venting to do, I'll do it in the SIBI thread. Don't want to sound like I'm hyping. Wanted to emphasize that I'm not strong in neuro, and that I don't know what to expect from 1508Y and 1553A.



To: scaram(o)uche who wrote (260)8/28/1998 3:44:00 PM
From: Joe WesleyRead Replies (2) | Respond to of 4974
 
Hi Rick:

FWIW I think the problem with CVAS was BVF made an error when they went to 21.4%. This violated the 20% provision CVAS recently passed and Mark decided to dump 215K shares to go back to 20%.

Also I've heard the NIF program is his reason for buying.

Hang in there Rick 10x candidates a month ago are now 20x.
Amateur